Johnson & Johnson

We’d like to share more about how we work and what drives our day-to-day business. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. dotbig The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction. Live educational sessions using site features to explore today’s markets.

JNJ stock

Company logos are from the logo database and belong to their respective copyright holders. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one Forex with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time. To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Key Earnings Data

TipRanks is a comprehensive investing tool that allows private investors and day traders to see the measured performance of anyone who provides financial advice. Johnson & Johnson has 1.97% upside potential, based on the analysts’ average price target. But making Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in trading on Thursday, shares of JNJ entered into oversold territory, changing hands as low as $167.41 per share. Data, information, or opinions contained in Quantalytics in any form give no consideration to Johnson & Johnson stock price today any particular individuals’ investment needs or objectives, nor do they consider any individuals’ financial condition. Consequently, any such data, information, or opinions do not in any way represent a personal recommendation to any individual investor or any entities, whatever the type. C-RATED STOCKS are those stocks our Big Data multi-factor models score as probable to have negligible return for the month. JNJ is a dividend king with strong portfolio of products and a rare AAA credit rating, making an investment in JNJ about as reliable as they come.

  • In a time of much uncertainty surrounding 2023, JNJ is a defensive name with essential products with a rock-solid dividend.
  • Mark Roussin is an active Certified Public Accountant in the state of California.
  • Quantalytics does not make any representations as to their accuracy or completeness.
  • Although consumer health has been the backbone of the company over the years, the pharmaceutical and medical device sales segments have been the growth drivers.
  • As an investor, you want to buy stocks with the highest probability of success.
  • Pharmaceutical and MedTech have been growth drivers growing above or near double digit returns on average over the past few years.

This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a lower news sentiment than the 0.33 average news sentiment score of Medical companies. The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.

Top-Rated Large-Cap Stocks to Buy and Hold

A-RATED STOCKS are those stocks the Big Data multi-factor models score as most probable to rise in price. Johnson & Johnson is one of the iconic companies here in the US, but they going to be going through some major changes in 2023 as they split up the business, Johnson & Johnson stock price today moving consumer health into its own company called Kenvue. JNJ will be spinning off its popular consumer health segment into a separate company called Kenvue. 2,535 employees have rated Johnson & Johnson Chief Executive Officer Alex Gorsky on

Nov 10, 2022 The company is planting seeds for future growth. This also came in above analysts’ estimate of $23.34 billion for the quarter.

More Tuesday Stock Market News

The healthcare sector consists of companies that provide medical services, manufacture medical equipment or drugs, provide medical insurance, or otherwise facilitate the provision of healthcare to patients. Bifurcation is when one company divides into two, creating two new companies that can each sell shares to stockholders. One will get its many consumer brands, while the other will get its pharmaceuticals, medical devices, and medical technology businesses. Real-time analyst ratings, insider transactions, earnings data, and more.

Price Target and Rating

Johnson and Johnson stock is rising ahead of the spinoff of its consumer health division next year. Its consistent dividend, buybacks, and free cash flow make JNF stock attractive to value buyers. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people JNJ stock price today worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers. D-RATED STOCKS are those stocks our Big Data multi-factor models score as moderately probable to fall in price.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment.

Investors of record on Tuesday, November 22nd will be paid a dividend of $1.13 per share on Tuesday, December 6th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date of this dividend is Monday, November 21st. Johnson & Johnson has a short interest ratio (“days to cover”) of 1.8, which is dotbig generally considered an acceptable ratio of short interest to trading volume. According to analysts’ consensus price target of $182.00, Johnson & Johnson has a forecasted upside of 1.7% from its current price of $178.88. Moreover, the company posted revenue of $24 billion, an increase of 3% year-on-year , beating expectations by $180 million.

The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

Tags: No tags

Add a Comment

Your email address will not be published. Required fields are marked *